Primo Chemicals quarterly results

Q1 FY27 · Apr–Jun 2026
₹ croreQ1 FY27Q1 FY26Change
Revenue140142−1.2%
EBITDA20.820.4+2.0%
EBITDA margin14.8%14.4%+0.5 pts
Profit before tax8.97.1+25.0%
Net profit4.74.1+14.9%
EPS₹0.19₹0.17+11.8%

Every quarter

₹ crore except per share
Tap a line for its trendQ1 FY27Jun 2026Q4 FY26Mar 2026Q3 FY26Dec 2025Q2 FY26Sep 2025Q1 FY26Jun 2025Q4 FY25Mar 2025
140145140135142155
5.25.64.44.55.34.4
146151145139147160
Expenses
83.089.681.587.985.386.2
0.04.911.40.00.06.0
2.0−4.21.0−0.10.1−2.0
11.811.512.011.612.012.9
3.73.94.34.85.55.8
13.513.013.213.213.112.5
22.724.120.620.024.228.5
137143144138140150
20.819.013.615.320.424.0
7.36.00.32.17.311.4
Profit
8.97.80.41.77.110.1
0.00.0−0.20.00.00.0
8.97.80.21.77.110.1
2.11.4−0.00.41.21.8
3.11.40.6−1.42.89.4
5.22.70.5−1.14.011.2
1.01.01.41.41.00.7
4.76.11.14.24.1−0.4
3.65.1−0.32.83.1−1.1
−0.3−0.20.20.1−0.10.1
4.35.91.34.34.0−0.3
—6.1——4.1—
Per share
₹0.19₹0.25₹0.04₹0.17₹0.17−₹0.01
₹0.19₹0.25₹0.04₹0.17₹0.17−₹0.01
Other comprehensive income — detail
−0.3−0.20.20.1−0.10.1
−0.5−0.30.30.2−0.20.1
−0.2−0.10.10.1−0.10.0
————4.1—
Per share — as-filed variants
₹0.19₹0.25₹0.04₹0.17₹0.17−₹0.01
₹0.19₹0.25₹0.04₹0.17₹0.17−₹0.01
Derived — gross profit (revenue − materials − purchases − Δ inventories)
55.354.646.247.056.665.3
39.4%37.7%33.0%34.9%39.9%42.0%
Adjusted (ex-exceptional items) — derived
8.97.80.41.77.110.1
0.00.0−0.20.00.00.0
4.76.11.14.24.1−0.4
₹0.19₹0.25₹0.04₹0.17₹0.17−₹0.01
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

PRIMO₹22.90

Primo Chemicals Limited

· Chemicals
AnnualQuarterly₹ CrorePeersCHEMFABPLASTIBLENMANORGLORDSCHLOKRONOXJAYAGROGNDMCCHPALMcap ₹555 Cr
View
In ₹ Crore except Per Share
3 Months Ending
Q4 FY25
31/03/2025
Q1 FY26
30/06/2025
Q2 FY26
30/09/2025
Q3 FY26
31/12/2025
Q4 FY26
31/03/2026
Q1 FY27
30/06/2026
Revenue from Operations155.4141.9134.7140.1144.9140.3
Other Income4.45.34.54.45.65.2
Total Income159.8147.2139.2144.6150.5145.5
Expenses
+ Cost of Materials Consumed86.285.387.981.589.683.0
+ Purchases of Stock-in-Trade6.00.00.011.44.90.0
+ Changes in Inventories-2.00.1-0.11.0-4.22.0
+ Employee Benefit Expense12.912.011.612.011.511.8
+ Finance Costs5.85.54.84.33.93.7
+ Depreciation & Amortisation12.513.113.213.213.013.5
+ Other Expenses28.524.220.020.624.122.7
Total Expenses149.7140.1137.5144.1142.7136.7
EBITDA24.020.415.313.619.020.8
EBIT11.47.32.10.36.07.3
Profit
PBT before Exceptional Items10.17.11.70.47.88.9
+ Exceptional Items0.00.00.0-0.20.00.0
Pretax Income10.17.11.70.27.88.9
+ Current Tax1.81.20.4-0.01.42.1
+ Deferred Tax9.42.8-1.40.61.43.1
Tax Expense11.24.0-1.10.52.75.2
+ Share of Associates & JVs0.71.01.41.41.01.0
Net Income-0.44.14.21.16.14.7
+ Net Income — Continuing Ops-1.13.12.8-0.35.13.6
+ Other Comprehensive Income0.1-0.10.10.2-0.2-0.3
Total Comprehensive Income-0.34.04.31.35.94.3
Net Income to Common—4.1——6.1—
Per Share
Basic EPS-0.010.170.170.040.250.19
Diluted EPS-0.010.170.170.040.250.19
Other Comprehensive Income — detail
+ Other Comprehensive Income0.1-0.10.10.2-0.2-0.3
+ Items NOT to be Reclassified to P&L0.1-0.20.20.3-0.3-0.5
+ Tax on Items NOT to be Reclassified0.0-0.10.10.1-0.1-0.2
Comprehensive Income — Owners of Parent—4.1————
Per Share — as-filed variants
Basic EPS — Continuing Operations-0.010.170.170.040.250.19
Diluted EPS — Continuing Operations-0.010.170.170.040.250.19
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit65.356.647.046.254.655.3
Gross Margin %42.0139.8734.8632.9937.6639.43
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)10.17.11.70.47.88.9
− Exceptional Items (reconciliation)0.00.00.0-0.20.00.0
Net Income Adj (tax-effected)-0.44.14.21.16.14.7
EPS Adj-0.010.170.170.040.250.19
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value2.002.002.002.002.002.00
Filed Debt Equity—0.300.25———
Filed Dscr—0.471.00———
Filed Iscr—0.551.85———
Paid Up Equity Capital48.548.548.548.548.548.5
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: Q1 FY27 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.

Primo Chemicals Q2 FY27 results date

Primo Chemicals (NSE: PRIMO) will announce its Q2 FY27 results (July–September 2026) on Monday, 2 November 2026, according to the board-meeting notice it filed on 26 October 2026. Its latest results are for Q1 FY27 (April–June 2026). Consolidated net profit was ₹4.7 crore, up 14.9% from ₹4.1 crore in Q1 FY26 and down 22.9% from ₹6.1 crore in Q4 FY26. Revenue from operations was ₹140 crore, down 1.2% year on year and down 3.2% from the previous quarter.

Board-meeting notice filed
26 October 2026
Q2 FY26 results (a year earlier)
14 November 2025
Q1 FY27 results (the latest)
14 August 2026

Latest results: Q1 FY27 (Apr–Jun 2026) · consolidated

Q2 FY27 results date
2 November 2026Monday · notice filed 26 Oct
Q1 FY27 net profit
₹4.7 Cr+14.9% vs Q1 FY26−22.9% vs Q4 FY26
Q1 FY27 revenue
₹140 Cr−1.2% vs Q1 FY26−3.2% vs Q4 FY26
Q1 FY27 operating margin
5.2%+0.1 pts vs Q1 FY26+1.0 pts vs Q4 FY26
Q2 FY26 net profit (a year earlier)
₹4.2 CrRevenue ₹135 Cr
Q1 FY27 EPS (basic)
₹0.19

Questions

When will Primo Chemicals announce its Q2 FY27 results?

On 2 November 2026, the date of the board meeting called to approve them (notice filed with the exchanges on 26 October 2026). Last year it reported Q2 FY26 on 14 November 2025.

What will Primo Chemicals' Q2 FY27 results be compared with?

With the same quarter a year earlier, Q2 FY26 (July–September 2025), when consolidated net profit was ₹4.2 crore and revenue from operations ₹135 crore. The latest quarter, Q1 FY27, had a net profit of ₹4.7 crore and revenue of ₹140 crore.

What were Primo Chemicals' Q1 FY27 results?

Consolidated net profit was ₹4.7 crore, up 14.9% from ₹4.1 crore in Q1 FY26 and down 22.9% from ₹6.1 crore in Q4 FY26. Revenue from operations was ₹140 crore, down 1.2% year on year and down 3.2% from the previous quarter.

How has Primo Chemicals' profit changed over the last four quarters?

Net profit by quarter: ₹4.2 crore in Q2 FY26, ₹1.1 crore in Q3 FY26, ₹6.1 crore in Q4 FY26 and ₹4.7 crore in Q1 FY27. That is ₹16 crore over the four quarters. Revenue from operations: ₹135 crore, ₹140 crore, ₹145 crore and ₹140 crore.

What was Primo Chemicals' net profit in FY26?

Consolidated net profit was ₹15.4 crore in FY26 (April 2025–March 2026), up 331.8% from ₹3.6 crore in FY25.

What was Primo Chemicals' revenue in FY26?

Revenue from operations was ₹562 crore in FY26 (April 2025–March 2026), up 1.1% from ₹556 crore in FY25.

Where do these Primo Chemicals figures come from?

From Primo Chemicals' own consolidated results filings to NSE, in ₹ crore as filed; the date from its board-meeting notices.

Consolidated figures from the company's filings to NSE. Every company's results dates this season are in the Q2 FY27 results calendar, part of Alpha Plus.